Incidental adrenal tumors are common but are most often asymptomatic. The challenge for primary care providers is to determine the hormone secretion status and malignancy potential. This article outlines...
A 63-year-old man with hepatitis C, cirrhosis of the liver, end-stage liver disease, renal failure, and congestive heart failure, was brought to the hospital by ambulance for complaints of weakness in his...
Lupus nephritis can lead to endstage kidney disease, with catastrophic progression to ESKD within several years of onset relatively uncommon. What factors are associated with the risk of catastrophic...
If a patient presents with a GFR category G3a and a persistent albuminuria category of A2, to which risk category does he or she belong? Test your knowledge with our latest pop quiz!
In FIGARO-DKD, the primary outcome measure is a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Of these outcomes, do...
In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease (CKD) and discuss how the current definition of CKD does not...
In this video, Eric Gottlieb, MD, MS, discusses the use of cystatin C vs creatinine to estimate glomerular filtration rate in diverse patient populations and how the use of cystatin C to estimate GFR can...
05/02/2023
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 4
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 4
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...